Int J Food Microbiol 2010, 141:82–89.CrossRefPubMed 27. Villena J, Racedo S, Agüero G, Bru E, Medina M, Alvarez S: Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 2005, 135:1462–1469.PubMed 28. O’Hara AM, O’Regan P, Fanning A, Mahony C, Macsharry J, Lyons A, Bienenstock J, O’Mahony F: Shanahan, Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius . Immunol 2006, 118:202–215.CrossRef 29. Zhang L, Li N, Caicedo R, Neu selleck products J: Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8
production in Caco-2 cells. J Nutr 2005, 135:1752–1756.PubMed 30. Cheung PC, Campbell DG, Nebreda AR, Cohen P: Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J 2003, 22:5793–5805.CrossRefPubMed 31. Muniyappa H, Das KC: Activation of c-Jun N.-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK3–MKK7-dependent mechanism. Cell Signal 2008, 20:675–683.CrossRefPubMed 32. Liew FY, Brint XD, EK O, Neill LA: Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446–458.CrossRefPubMed
33. Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF: Bcl-3 and NF‐κB p50 attenuate lipopolysaccharide‐induced inflammatory responses in macrophages. J Biol Chem 2004, 279:49995–50003.CrossRefPubMed
34. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J, Volpe F: Tollip, a new component of the R788 cell line IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000, 2:346–351.CrossRefPubMed 35. Zhang G, Ghosh S: Negative regulation of toll-like receptor- mediated signaling by Tollip. J Biol Chem 2002, 277:7059–7065.CrossRefPubMed 36. Otte JM, Cario E, Podolsky DK: Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterol 2004, 126:1054–1070.CrossRef Competing interests second The authors declare that they have no competing interests. Authors’ contributions NT, YT, JV and HK conceived the study; NT, YT, JV, SI, HI, TS and HK designed the study; NT, YT, JV, KM, TT and EC did the laboratory work. NT, YT, JV, MT, TS, HA, YS, YK, HK analysed the data. NT, YT, JV and HK wrote the manuscript; all authors read and approved the manuscript.”
“Background The discovery and development of antibiotics have revolutionised medicine in the 20th century. However their widespread and sometimes AR-13324 chemical structure negligent usage led to the phenomenon of antibiotic resistance which reduced their efficiency as therapeutic agents [1]. Nowadays, diseases caused by bacterial pathogens resistant to variety of antimicrobial agents are more frequent in medical practice than just a few years ago. This issue has huge impact in terms of lives and health care expenses [2].
Related posts:
- BJU Int 2007, 99: 1223–1229 CrossRefPubMed 16 Jones TD, Eble JN,
- Cancer Genet Cytogenet 2003, 140: 145–152 CrossRefPubMed 10 Cher
- Int J Radiat Biol 2000, 76: 1297–1303 CrossRefPubMed 8 Courdi A,
- Clin Infect Dis 2007, 44:977–980 CrossRefPubMed 18 Avrain L, Hum
- CrossRefPubMed 37 Sabet NS, Subramaniam G, Navaratnam P, Sekaran